Investigating airway epithelial cells in asthma patients
Official title: Core-001
Funded at University of Washington · NIH-11281355 · Data updated 2026-11-12
This study is looking at airway cells from people with asthma and those without to learn more about the different types of asthma and how they affect patients, with the hope of finding better, personalized treatments for asthma in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | April 25, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $472,124 |
| NIH project number | 5U19AI175089-03 |
| Project ID | NIH-11281355 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with asthma, both children and adults, who are scheduled for elective surgery.
✕Less likely to help
Patients who do not have asthma or are not undergoing elective surgery may not benefit from this research.
What this research studies
This research focuses on collecting and analyzing airway epithelial cells from individuals with asthma and healthy controls to better understand the different clinical phenotypes of asthma. The study involves obtaining these cells during elective surgeries and using advanced culture techniques to create organotypic models. By characterizing these cells, researchers aim to correlate specific asthma phenotypes with clinical data over time, which could lead to more personalized treatment approaches for asthma patients.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and management of asthma, potentially resulting in better-targeted therapies for patients.
How similar studies have gone: Similar research approaches have shown promise in understanding asthma phenotypes, indicating that this methodology is both relevant and potentially impactful.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Hallstrand, Teal S — University of Washington
- Study coordinator: Hallstrand, Teal S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.